KBI Biopharma ^Investors

KBI Biopharma is a leading biopharmaceutical contract services organization that specializes in drug development and biomanufacturing. With over 300 client partners, KBI offers personalized and accelerated drug development programs. They provide efficient process development and manufacturing services for mammalian, microbial, and cell therapy programs. KBI has multiple locations in the United States and Belgium, and is known for its world-class analytical capabilities and commitment to delivering high-quality services.